Delivery Order HHSN272201100019I-75N93018F00022

The U.S. Department of Health and Human Services' National Institute of Allergy and Infectious Diseases (NIAID) awarded a $96,035.00 firm fixed-price delivery order to Utah State University (USU) to conduct "IN VITRO ASSESSMENT FOR ANTIMICROBIAL ACTIVITY AGAINST RESPIRATORY VIRUSES." This award is under the "In Vitro Antimicrobial Assessments 2011-2018" indefinite delivery, indefinite quantity (IDIQ) contract. USU, a public land-grant research university, will provide its...

The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $466,684.00 firm fixed price delivery order to Utah State University (USU) to determine the antiviral inhibitory effect and cytotoxicity of experimental antiviral compounds against viruses listed in the statement of work, as well as other rapidly emerging viruses using the same assay methodology. This delivery order is part of the In Vitro Assessments of...

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded Utah State University a $669,786 firm fixed price delivery order against the In Vitro Assessments of Antimicrobial Activity master IDIQ contract. USU will perform a comprehensive viral screening panel under this award to determine the antiviral inhibitory effect and cytotoxicity of experimental antiviral compounds against viruses as well as other rapidly emerging viruses that utilize the same...

Utah State University has been awarded a delivery order against the In Vitro Assessments of Antimicrobial Activity indefinite delivery contract held by the National Institute of Allergy and Infectious Diseases. This $431,621 firm fixed price order tasks Utah State University to determine the antiviral inhibitory effect and cytotoxicity of experimental antiviral compounds against viruses in Groups 3-5, as well as other rapidly emerging viruses that utilize the same assay methodology....

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded Utah State University a $354,191 firm fixed price delivery order against the In Vitro Assessments of Antimicrobial Activity master IDIQ contract. Under this order, USU will determine the antiviral inhibitory activity and cytotoxicity of test molecules against respiratory viruses using specified test methods to identify actively compounds for further investigation. The work will be performed in...

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $339,045.00 firm fixed-price delivery order to Utah State University (USU) to conduct in vitro assessments of antimicrobial activity against respiratory viruses. This award is part of a larger indefinite delivery contract vehicle called "In Vitro Assessments of Antimicrobial Activity (IVAAA)." USU, a public research university and 1862 land-grant institution, has extensive experience...

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to Utah State University (USU) for $150,742.00. The contract is a Delivery Order under the "In Vitro Antimicrobial Assessments 2011-2018" Indefinite Delivery/Indefinite Quantity (IDIQ) Master Contract. USU, as a large public research university, will provide in vitro assessments of compounds against a comprehensive virus...

Utah State University has been awarded an $869,722 firm fixed price delivery order against the In Vitro Assessments of Antimicrobial Activity (IVAAA) master IDIQ contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The order is for in vitro assessment for antimicrobial activity against respiratory viruses with a completion date of June 14, 2024. No set-aside designation was specified. Utah State University will leverage its capabilities developed...

This firm fixed price delivery order, valued at $767,181, was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Utah State University, doing business as USU, to determine the antiviral inhibitory effect and cytotoxicity of experimental antiviral compounds against viruses listed in Groups 4 through 7 as well as other rapidly emerging viruses. The contract was issued against the In Vitro Assessments of Antimicrobial Activity master IDIQ vehicle...

This is a definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Utah State University (USU) for an "In Vitro Antiviral Screening Program - Respiratory Viruses". The contract has a ceiling value of $9,418,875.32 and was awarded on September 15, 2003, with a completion date of September 29, 2010. The contract is for cost-reimbursement services without a fee. No set-aside designation...